newsfilter
← Latest News
ClinicalTrials.gov·

vGRID SBRT: A Phase I Clinical Trial in Unresectable HCC - NCT05727787

Maximum tolerated dose (MTD) of Single Fraction GRID SBRT, Local control utilizing RECIST v1.1 for HCC., Regional failure utilizing RECIST v1.1 for HCC., (and 3 more...)